The FDA withdraws the emergency use authorization of Evusheld, which was touted as a COVID prevention tool
The US Food and Drug Administration is withdrawing its emergency use authorization of a COVID antibody therapy because it's unlikely to be effective against variants. Evusheld, which is made by British Swedish pharmaceutical and biotechnology company, AstraZeneca, was first authorized in December 2021 as preexposure protective treatment against the virus ...



